Xu Jian-Min, Yang Huan-Dong, Tian Xiang-Ping
Clin Nephrol. 2019 Nov;92(5):243-249. doi: 10.5414/CN109435.
To study the effects of early continuous veno-venous hemofiltration (CVVH) on organ function and intra-abdominal pressure (IAP) in severe acute pancreatitis (SAP) patients with abdominal compartment syndrome (ACS).
48 SAP patients with ACS were included in this study. Among them, 37 patients, receiving both conventional treatment and hemofiltration therapy in the ICU, were regarded as the treatment group, and the rest, receiving only conventional treatment, were regarded as the control group. Symptoms, signs, and adverse reactions of both groups were observed and recorded during treatments. Serum and urine amylase, liver and kidney function, C-reactive protein, and intra-abdominal pressure of the patients were detected before and on days 1, 2, 3, 4, 5, and 6 after treatment.
Early hemofiltration in SAP with ACS can effectively reduce intra-abdominal pressure, improve symptoms, accelerate liver and renal function recovery, avoid multiple organ failure and decrease mortality rate.
研究早期连续性静脉-静脉血液滤过(CVVH)对伴有腹腔间隔室综合征(ACS)的重症急性胰腺炎(SAP)患者器官功能及腹内压(IAP)的影响。
本研究纳入48例伴有ACS的SAP患者。其中,37例在重症监护病房接受常规治疗及血液滤过治疗的患者作为治疗组,其余仅接受常规治疗的患者作为对照组。治疗期间观察并记录两组患者的症状、体征及不良反应。检测患者治疗前及治疗后第1、2、3、4、5、6天的血清及尿淀粉酶、肝肾功能、C反应蛋白及腹内压。
伴有ACS的SAP患者早期进行血液滤过可有效降低腹内压,改善症状,加速肝肾功能恢复,避免多器官功能衰竭并降低死亡率。